Aubrey Capital Management LTD Exact Sciences Corp Transaction History

Aubrey Capital Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$55.75 - $92.75 $2.89 Million - $4.8 Million	-51,750 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$37.9 - $104.44 $37,900 - $104,440	-1,000 Reduced 1.9%	51,750 $3 Million
Q3 2019 Nov 04, 2019	BUY	$90.37 - $122.49 $180,740 - $244,980	2,000 Added 3.94%	52,750 $4.77 Million
Q1 2019 May 14, 2019	BUY	$61.98 - $96.5 $635,295 - $989,125	10,250 Added 25.31%	50,750 $0
Q4 2018 Feb 13, 2019	BUY	$56.04 - $82.66 $1.43 Million - $2.11 Million	25,500 Added 170.0%	40,500 $2.56 Billion
Q3 2018 Nov 08, 2018	BUY	$48.29 - $80.6 $724,350 - $1.21 Million	15,000 New	15,000 $0

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Aubrey Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Aubrey Capital Management LTD with notifications on news.